EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states

Hedieh Sattarifard, Akram Safaei, Enzhe Khazeeva, Mojgan Rastegar, James R Davie iD

Biochemistry and Cell Biology · 01.06.2023 · 101 (3) · 204-219

DOI: 10.1139/bcb-2022-0371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.06.2023. Verfasst von Hedieh Sattarifard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, MB, Canada. Hauptthemen laut MEDLINE: Histones, Mitogens. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mitogen- and stress-activated protein kinases (MSK) are epigenetic modifiers that regulate gene expression in normal and disease cell states. MSK1 and 2 are involved in a chain of signal transduction events bringing signals from the external environment of a cell to specific sites in the genome. MSK1/2 phosphorylate histone H3 at multiple sites, resulting in chromatin remodeling at regulatory elements of target genes and the induction of gene expression. Several transcription factors (RELA of NF-κB and CREB) are also phosphorylated by MSK1/2 and contribute to induction of gene expression. In response to signal transduction pathways, MSK1/2 can stimulate genes involved in cell proliferation, inflammation, innate immunity, neuronal function, and neoplastic transformation. Abrogation of the MSK-involved signaling pathway is among the mechanisms by which pathogenic bacteria subdue the host’s innate immunity. Depending on the signal transduction pathways in play and the MSK-targeted genes, MSK may promote or hinder metastasis. Thus, depending on the type of cancer and genes involved, MSK overexpression may be a good or poor prognostic factor. In this review, we focus on mechanisms by which MSK1/2 regulate gene expression, and recent studies on their roles in normal and diseased cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesMitogensGene ExpressionPhosphorylationProtein KinasesHumansAnimalsRibosomal Protein S6 Kinases, 90-kDa

Stichwörter der Autor:innen

MSK1/2cancerepigeneticsimmunityinflammationneurodevelopment

Substanzen

HistonesMitogensProtein Kinasesmitogen and stress-activated protein kinase 1Ribosomal Protein S6 Kinases, 90-kDaRPS6KA4 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, MB, Canada.

ORCID-Profile: James R Davie

Förderung

  • CIHR

Zitieren

APA

Sattarifard, H., Safaei, A., Khazeeva, E., Rastegar, M., & Davie, J. R. (2023). Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states. Biochemistry and Cell Biology, 101(3), 204-219. https://doi.org/10.1139/bcb-2022-0371

Vancouver

Sattarifard H, Safaei A, Khazeeva E, Rastegar M, Davie JR. Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states. Biochemistry and Cell Biology. 2023;101(3):204-219. doi:10.1139/bcb-2022-0371

BibTeX
@article{Sattarifard2023,
  author = {Sattarifard, Hedieh and Safaei, Akram and Khazeeva, Enzhe and Rastegar, Mojgan and Davie, James R},
  title = {Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states},
  journal = {Biochemistry and Cell Biology},
  year = {2023},
  volume = {101},
  number = {3},
  pages = {204--219},
  doi = {10.1139/bcb-2022-0371}
}
Kostenlos starten →